Profile of romosozumab and its potential in the management of osteoporosis
Sian Yik Lim,1 Marcy B Bolster2 1Straub Bone & Joint Center, Straub Medical Center, Honolulu, HI, 2Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Abstract: Increased understanding of bone biology has led to th...
Main Authors: | Lim SY, Bolster MB |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/profile-of-romosozumab-and-its-potential-in-the-management-of-osteopor-peer-reviewed-article-DDDT |
Similar Items
-
Romosozumab and blosozumab: alternative drugs of mechanical strain-related stimulus toward a cure for osteoporosis
by: Toshihiro eSugiyama, et al.
Published: (2015-04-01) -
Sclerostin antibodies as novel anabolic therapy for osteoporosis
by: Elizaveta O. Mamedova, et al.
Published: (2019-04-01) -
Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study
by: Takeshi Mochizuki, et al.
Published: (2021-09-01) -
Romosozumab and cardiovascular safety in Japan
by: Yasuhiro Takeuchi
Published: (2021-09-01) -
Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study
by: Tomonori Kobayakawa, et al.
Published: (2021-06-01)